Home / Inspections / 1259069

FDA Inspection 1259069 — DeGowin Blood Center

DeGowin Blood Center — FEI 1972918

The FDA completed an inspection of DeGowin Blood Center on December 12, 2024 in Iowa City, IA. The inspection was classified NAI (No Action Indicated — no objectionable conditions were found). Product area: Biologics.

Inspection Details

Classification
No Action Indicated (NAI) (NAI)
End Date
December 12, 2024
Fiscal Year
2025
Product Type
Biologics
Project Area
Blood and Blood Products
Location
Iowa City, IA (United States)

Facility

Other inspections at this facility

  • 1094007 (NAI Thu Jun 06 2019 00:00:00 GMT+0000 (Coordinated Universal Time))
  • 1001567 (NAI Wed Feb 15 2017 00:00:00 GMT+0000 (Coordinated Universal Time))
  • 915232 (VAI Fri Feb 13 2015 00:00:00 GMT+0000 (Coordinated Universal Time))
  • 805206 (VAI Wed Oct 24 2012 00:00:00 GMT+0000 (Coordinated Universal Time))
  • 696431 (NAI Wed Nov 03 2010 00:00:00 GMT+0000 (Coordinated Universal Time))

FDA data resources